C07D 513/12
In which the condensed system contains three hetero rings
Official title: in which the condensed system contains three hetero rings
C07D513/12 (In which the condensed system contains three hetero rings) appears on 627 US grants and 702 published applications in this corpus.
Search patents in C07D- Granted patents
- 627
- Published applications
- 702
- Assignees
- 404
- Inventors
- 2,575
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 0 | 0 |
| 1978 | 12 | 0 |
| 1979 | 7 | 0 |
| 1980 | 8 | 0 |
| 1981 | 5 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 3 | 0 |
| 1986 | 3 | 0 |
| 1987 | 8 | 0 |
| 1988 | 7 | 0 |
| 1989 | 8 | 0 |
| 1990 | 9 | 0 |
| 1991 | 7 | 0 |
| 1992 | 10 | 0 |
| 1993 | 6 | 0 |
| 1994 | 6 | 0 |
| 1995 | 7 | 0 |
| 1996 | 11 | 0 |
| 1997 | 16 | 0 |
| 1998 | 9 | 0 |
| 1999 | 5 | 0 |
| 2000 | 6 | 0 |
| 2001 | 5 | 1 |
| 2002 | 6 | 10 |
| 2003 | 7 | 13 |
| 2004 | 7 | 17 |
| 2005 | 9 | 15 |
| 2006 | 7 | 14 |
| 2007 | 7 | 7 |
| 2008 | 10 | 11 |
| 2009 | 4 | 21 |
| 2010 | 7 | 20 |
| 2011 | 15 | 38 |
| 2012 | 20 | 28 |
| 2013 | 30 | 33 |
| 2014 | 28 | 50 |
| 2015 | 35 | 26 |
| 2016 | 32 | 27 |
| 2017 | 28 | 33 |
| 2018 | 20 | 29 |
| 2019 | 25 | 26 |
| 2020 | 25 | 31 |
| 2021 | 20 | 42 |
| 2022 | 31 | 34 |
| 2023 | 23 | 59 |
| 2024 | 28 | 49 |
| 2025 | 23 | 37 |
| 2026 | 12 | 31 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Materials for organic electroluminescent devices15 Sep 2026US 12,735,436 B2Universal Display Corporation
- Pyrazole-containing polycyclic derivative inhibitor, preparation method therefor and application thereof11 Aug 2026US 12,703,701 B2Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Tricyclic triazolo compounds as DGK inhibitors28 Jul 2026US 12,692,276 B2Incyte Corporation
- Macrocyclic compounds, compositions, and methods of using thereof9 Jun 2026US 12,649,750 B2Genzyme Corporation
- Method for introducing deuterated lower alkyl into amine moiety of compound containing secondary amine19 May 2026US 12,630,487 B2Otsuka Pharmaceutical Co., Ltd.
- Compounds as sumo activating enzyme inhibitors1 Oct 2026US 2026/0297109 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Ras inhibitors1 Oct 2026US 2026/0297112 A1Revolution Medicines, Inc.
- Nitrogenous heterocycles for organic electroluminescent devices17 Sep 2026US 2026/0282745 A1UDC Ireland Limited
- Imidazodiazepinediones and methods of use thereof27 Aug 2026US 2026/0250295 A1Gfb (Abc), LLC
- Degrader compounds of qsox1 mrna27 Aug 2026US 2026/0250738 A9University of Florida Research Foundation, Inc.
Most cited
By later US patents
- Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof270US 6,110,929 A3M Innovative Properties Company · 2000
- Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family225US 5,654,307 AWarner-Lambert Company · 1997
- 4-Hydroxy-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxides and salts thereof142US 4,233,299 ABoehringer Ingelheim GmbH · 1980
- Substituted pyridoindoles as serotonin agonists and antagonists112US 6,699,852 B2Bristol-Myers Squibb Pharma Company · 2004
- Substituted heterocycle fused gamma-carbolines105US 7,071,186 B2Bristol-Myers Squibb Pharma Company · 2006